Pharming Group N.V. Overview

Pharming Group N.V. Cost of Revenue

Cost of Revenue analysis for PHAR.

Quarterly Cost of Revenue

$6.67M

↓ 19.88% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$40.80M

↑ 15.35% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin